258 related articles for article (PubMed ID: 21712626)
1. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.
Salehinejad J; Zare-Mahmoodabadi R; Saghafi S; Jafarian AH; Ghazi N; Rajaei AR; Marouzi P
J Oral Sci; 2011 Jun; 53(2):213-7. PubMed ID: 21712626
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid odontogenic tumor.
Barboza CA; Pereira Pinto L; Freitas Rde A; Costa Ade L; Souza LB
Braz Dent J; 2005; 16(1):56-61. PubMed ID: 16113935
[TBL] [Abstract][Full Text] [Related]
3. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors.
Sharifi-Sistani N; Zartab H; Babakoohi S; Saghravanian N; Jamshidi S; Esmaili H; Mohtasham N; Zamanzadeh M; Abbaszadeh-Bidokhty H
J Craniofac Surg; 2011 Sep; 22(5):1652-6. PubMed ID: 21959406
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein immunoexpression in selected benign epithelial odontogenic tumors.
Johann AC; Caldeira PC; Souto GR; de Abreu MH; Aguiar MC; Mesquita RA
J Oral Pathol Med; 2014 Mar; 43(3):177-82. PubMed ID: 24125466
[TBL] [Abstract][Full Text] [Related]
6. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.
de Medeiros AM; Nonaka CF; Galvão HC; de Souza LB; Freitas Rde A
Eur Arch Otorhinolaryngol; 2010 Feb; 267(2):303-10. PubMed ID: 19466441
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study.
Karathanasi V; Tosios KI; Nikitakis NG; Piperi E; Koutlas I; Trimis G; Sklavounou A
J Oral Pathol Med; 2013 May; 42(5):415-23. PubMed ID: 23157422
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
9. Argyrophilic nucleolar organizer regions (AgNORs) in ameloblastomas and adenomatoid odontogenic tumours (AOTs).
do Carmo MA; Silva EC
J Oral Pathol Med; 1998 Apr; 27(4):153-6. PubMed ID: 9563569
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle aberration in ameloblastoma and adenomatoid odontogenic tumor: As evidenced by the expression of p53 and survivin.
Shaikh Z; Niranjan KC
Indian J Dent Res; 2015; 26(6):565-70. PubMed ID: 26888232
[TBL] [Abstract][Full Text] [Related]
11. Comparison of proliferating cell nuclear antigen expression in odontogenic keratocyst and ameloblastoma: an immunohistochemical study.
Takahashi H; Fujita S; Yamabe S; Moriishi T; Okabe H; Tajima Y; Mizuno A
Anal Cell Pathol; 1998; 16(4):185-92. PubMed ID: 9762365
[TBL] [Abstract][Full Text] [Related]
12. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
13. Comparative Immunohistochemical Analysis of p53 and Alpha-SMA in Ameloblastoma, AOT and OKC.
Adesina OM; Adebiyi KE; Effiom OA; Omoniyi-Esan GO; Owotade FJ; Fatusi OA; Kolude B; Odujoko OO; Ladeji A
West Afr J Med; 2022 Mar; 39(3):248-255. PubMed ID: 35366669
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of MMP-13 and EMMPRIN in epithelial odontogenic lesions.
de Andrade Santos PP; Nonaka CFW; Barboza CAG; Pereira Pinto L; de Souza LB
Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3203-3211. PubMed ID: 31440816
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs.
de Souza Andrade ES; Miguel MC; de Almeida Freitas R; Pereira Pinto L; Batista de Souza L
Int J Surg Pathol; 2008 Jul; 16(3):277-85. PubMed ID: 18573784
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Wnt/β-catenin pathway may be related to Regγ in benign epithelial odontogenic lesions.
Santos HBP; Medeiros HCM; Mafra RP; Miguel MCC; Galvão HC; de Souza LB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Jul; 128(1):43-51. PubMed ID: 30799234
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of BMP-2 and BMP-4 and their receptors, BMPR-IA and BMPR-II, in ameloblastomas and adenomatoid odontogenic tumors.
Nascimento MA; Nonaka CF; Barboza CA; Freitas RA; Pereira Pinto L; Souza LB
Arch Oral Biol; 2017 Jan; 73():223-229. PubMed ID: 27780042
[TBL] [Abstract][Full Text] [Related]
18. Expression of p63 and p73 in ameloblastomas.
Kumamoto H; Ohki K; Ooya K
J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of calretinin in ameloblastoma, adenomatoid odontogenic tumor, and keratocystic odontogenic tumor: a comparative study.
Koneru A; Hallikeri K; Nellithady GS; Krishnapillai R; Prabhu S
Appl Immunohistochem Mol Morphol; 2014; 22(10):762-7. PubMed ID: 25046230
[TBL] [Abstract][Full Text] [Related]
20. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
